Tuesday, October 31, 2017 6:20:56 AM
do you seriously believe Rega is dead ?
Sure the recent Pfizer new Lyrica version is not a positive, although they didn't get the OK for fibromyalgia, but why DEAD ?
Doog made an excellent DD on the patents and looks like something is happening both on PODRAS side and Regabatin as well.
What is that "something" is very hard to desume, given the company decision to keep everything in the dark.
One of the few reasons I decided to wait some more as an IPCI investor is Regabatin; PODRAS being the second one and Rexista the other one.
ANDAs became worthless to my investment case, since I believe that just a sudden flow of 3-4 approvals in 3-4 months (=impossible) will cause a share price increase. The IPCI reputation won't change with generics.
IPCI will be playing its future (as a NASDAQ company) in the next 6 months and only a partnership for either Rega, Rexista or Podras could make things good.
JMHO
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM